全球周邊血管內超音波（IVUS）市場：市場規模、佔有率和趨勢分析（2025-2032）

全球周邊血管內超音波市場報告

2025年，全球周邊血管內超音波市場規模超過2.4億美元。在預測期內，該市場預計將以6.9%的複合年成長率成長，到2032年將達到3.83億美元。

• 這份關於全球周邊血管內超音波（IVUS）市場的綜合報告涵蓋七個區域：北美、拉丁美洲、西歐、中東歐、中東、亞太地區和非洲。報告針對每個區域提供市場規模、銷售量分析和平均售價數據，並預測至2032年，展望市場未來發展趨勢。本報告的結構和順序與附件範例文件一致，並針對外周IVUS市場及其特定的臨床和商業性趨勢進行了專門分析。

本報告對全球周邊血管內超音波（IVUS）市場進行了詳細分析，包括截至2022年的歷史數據，以及銷售量、手術量、平均售價、市場規模、市場佔有率、成長趨勢和至2032年的預測。該報告還涵蓋了近期併購、公司簡介、產品系列以及該領域主要企業的競爭分析。儘管周邊血管介入影像技術屬於較專業的領域，但隨著醫生在複雜手術中越來越依賴即時血管可視化，其重要性日益凸顯。

影響市場格局的關鍵趨勢之一是高解析度成像技術和微型導管系統的持續發展。這些進步使醫生能夠更清晰地觀察血管結構，並在介入治療過程中更有效地進行操作。因此，血管內超音波（IVUS）在評估病變、確定支架尺寸、最佳化術後操作以及治療複雜解剖結構方面發揮越來越重要的作用。這在僅靠血管造影術可能無法提供足夠詳細資訊以做出可靠決策的手術中尤其重要。

此外，靜脈介入治療的日益普及以及由於人口老化和周邊動脈疾病盛行率上升而導致的周邊手術數量的穩定成長，也推動了市場成長。

市場概覽

全球血管內超音波（IVUS）市場涵蓋了用於在周邊血管手術中從血管腔內觀察血管的導管式影像設備。與使用造影劑和X血管造影術影像勾勒血管輪廓的血管造影不同，IVUS可提供血管大小、斑塊負荷、管腔形狀和血管壁結構的即時截面資訊。這使其成為手術中至關重要的工具，因為準確的解剖結構資訊有助於改善治療方案的發展和最終的手術效果。

隨著血管介入手術日益複雜，周邊血管內超音波（IVUS）的重要性也日益凸顯。如今，許多周邊血管手術都涉及較大的病灶、鈣化的解剖結構、靜脈閉塞、入路困難，或血管支架及其他植入尺寸選擇上的臨界點。在這些情況下，醫生往往需要比單純血管造影術更精確的資訊。 IVUS 能夠滿足這項需求，幫助醫生在手術過程中識別血管直徑、病變長度、斑塊成分和真腔位置。

整體而言，周邊血管內超音波（IVUS）市場定位於影像診斷、介入治療和術前規劃之間。雖然它本身並非治療方法，但在幫助醫生做出更佳治療決策方面發揮著至關重要的作用。隨著周邊介入治療不斷發展，日益複雜且更依賴影像診斷，其角色也日益重要。

市場促進因素

靜脈治療

全球周邊血管內超音波（IVUS）市場最強勁的驅動力之一是靜脈治療的成長。身為IVUS市場的領導者，飛利浦積極將其產品與靜脈介入治療結合，使得IVUS與深部靜脈手術緊密聯繫。 VIDIO試驗結果公佈後，IVUS在下腔靜脈、髂總靜脈、髂股動脈閉塞和股總靜脈閉塞等靜脈疾病的應用日益普及。

這一點至關重要，因為血管內超音波（IVUS）在深部靜脈手術中的應用率已超過50%。如此成熟的應用意味著靜脈手術不僅蘊藏未來的發展機遇，更成為重要的市場需求來源。隨著靜脈疾病診斷和治療的日益增多，預計這一市場領域將實現顯著成長。在許多此類病例中，IVUS正逐漸成為工作流程中不可或缺的一部分，因為它能夠提供血管直徑和病變等詳細資訊，而這些信息僅憑造影可能難以發現。

人口因素正在推動周邊血管治療的發展。

另一個主要的成長要素是全球人口老化。周邊動脈疾病的發生老齡化增加，尤其是在65歲及以上的患者。隨著全球老年人口數量的增加，周邊血管治療的總量預計也會增加。即使血管內超音波（IVUS）在這些治療中的應用率沒有顯著變化，治療數量的增加本身也會促進導管銷售的成長。

此因素具有結構性和長期性，並非局限於特定公司或適應症。相反，它反映了這樣一個事實：隨著周邊動脈疾病（PAD）負擔的加重，越來越多的患者將需要血管介入治療。隨著血管內超音波（IVUS）擴大用於指導周邊介入治療，病例總數的增加將推動該影像領域的持續發展。

血管內超音波在EVAR和TEVAR手術中的臨床益處

周邊血管內超音波（IVUS）在腔內血管修復術（EVAR）和胸主動脈腔內血管修復術（TEVAR）中也具有許多優勢。在這些手術中，當基於CT的測量結果處於臨界值，或解剖結構在初始掃描和實際手術之間發生變化時，IVUS可以輔助進行解剖評估。它還有助於在器械植入前確認關鍵尺寸，從而增強醫生對血管支架選擇和放置的信心。

此外，血管內超音波（IVUS）也有助於減少腔內血管修復術（EVAR）和胸主動脈腔內修復術（TEVAR）中造影劑的使用量。這非常有益，因為造影劑會引起患者不適，對於有腎功能損害風險的患者而言可能並不理想。在主動脈剝離病例中，IVUS 可提供特別重要的指導，因為它有助於確認器械是否位於血管真腔內。由於 IVUS 辨識夾層的準確性遠高於血管造影術，因此它是複雜主動脈治療中實用且具有重要臨床意義的輔助工具。

這些優勢意義重大，因為它們顯示血管內超音波（IVUS）不僅僅是一種病灶影像工具，在一些技術難度較高的血管手術中，它還可以作為手術確認手段。隨著腔內血管修復術（EVAR）和胸主動脈腔內修復術（TEVAR）的不斷發展，這將進一步促進血管內超音波的應用。

市場限制

資本投資成本限制了其廣泛應用。

全球周邊血管內超音波（IVUS）市場面臨的最大障礙是資本投資成本。 IVUS系統需要一次性導管和IVUS主機。導管的使用可以帶來持續的收入，但主機需要大量的初始投資。即使醫生認可其臨床價值，對成本較為敏感的醫院和醫療機構也可能不願意輕易採用這項技術。

這是一個至關重要的問題，因為部署的設備數量決定了導管的長期需求。如果醫療機構推遲購買主機，導管銷售的成長自然會受到限制。對於小規模的醫療機構或病例較少的機構而言，證明初始投資的合理性可能很困難，尤其是在存在其他影像或手術優先事項的情況下。

模糊的圖像和學習曲線

另一個重要的阻礙因素是影像解讀的難度。對於未經訓練的使用者來說，血管內超音波（IVUS）影像可能難以解讀。這些影像通常顆粒感較強，而且並不總是能提供其他成像技術中那樣直覺易懂的細節。醫生需要接受訓練並累積實務經驗，才能在日常工作中自信地運用這項技術。

雖然訓練負擔並不算過重，但確實存在。影像解讀技能的需求是推廣應用的一大障礙，尤其是在醫生時間有限或手術團隊已熟悉血管造影術的醫療機構中。這可能導致推廣實施延遲，並優先採用更熟悉的影像技術。

正在研發中的技術

周邊血管內超音波（IVUS）也面臨來自光學相干斷層掃描（OCT）和基於CT的血管成像等新興技術的競爭。雖然這些技術在周邊血管領域尚未成為標準，但它們在冠狀動脈手術中的廣泛應用以及保險公司對新技術持續的報銷政策表明，它們未來有可能發揮更大的影響力。

這一點之所以重要，原因之一是某些替代成像技術能夠產生更清晰的影像和更立體的解剖模型。這些功能有助於識別血管撕裂、血栓、組織脫垂和支架閉合不全等情況。隨著這些技術的不斷成熟，預計它們將佔據部分血管內超音波（IVUS）的市場。

市場覆蓋範圍和數據範圍

定量研究範圍

市場規模、市佔率、市場預測、市場成長率、銷售量、平均售價。

定性研究範圍

市場促進因素和阻礙因素、成長趨勢、近期併購、公司概況、產品系列和主要競爭對手。

目標期

基準年：2025 年，歷史資料：截至 2022 年，預測：截至 2032 年。

按地區定位

北美洲、拉丁美洲、西歐、中歐和東歐、中東、亞太地區、非洲。

包含的資料類型

銷售量、平均售價、治療次數、市場規模和成長趨勢。

本報告旨在透過結合詳細的市場規模分析和對 IVUS 為周邊血管介入治療帶來的價值的實用見解，為策略規劃和競爭基準分析提供支援。

目標市場及區隔

本報告涵蓋了周邊血管內超音波的全球市場。

本報告將該市場作為周邊血管介入領域的一個專門影像類別進行分析。雖然本報告不像某些大規模治療市場那樣將該類別細分為多個設備系列，但它基於銷售量、平均售價 (ASP)、市場價值、成長率和區域表現對整體市場進行了評估。

此分析有助於了解周邊血管內超音波在動脈、靜脈和 EVAR（經皮血管主動脈置換術）或 TEVAR（經皮靜脈主動脈置換術）手術中的應用，包括到 2032 年的預測和 2022 年的歷史資料。

競爭分析

截至2025年，飛利浦在周邊血管內IVUS導管市場佔有領先地位。本公司提供豐富的周邊血管內IVUS導管組合，包括Visions PV .018、Visions PV .035、Visions PV .014P和Visions PV .014P RX。其Eagle Eye Platinum和Eagle Eye Platinum ST導管也應用於冠狀動脈和周圍血管手術，並與Core和Core Mobile IVUS主機相容。飛利浦的相位陣列IVUS導管通常被認為比旋轉式IVUS導管更容易操作，更符合工作流程，這賦予了公司顯著的競爭優勢。此外，飛利浦也是唯一一家提供全系列0.014吋、0.018吋和0.035吋周圍IVUS導管的主要供應商，進一步鞏固了其在動脈和靜脈適應症領域的市場地位。其強大的市場地位，尤其是在靜脈領域，仍然是其領先地位最清晰的證明之一。

波士頓科學公司在2025年周邊血管內超音波（IVUS導管市場排名第二。其領先地位得益於OptiCross18周邊IVUS導管，該導管可與iLab和POLARIS系統搭配使用。波士頓科學公司在周邊動脈疾病應用領域擁有良好的業績記錄，這得益於其豐富的產品系列組合以及將IVUS與輔助治療器械結合的能力。然而，其導管尺寸範圍不如飛利浦廣泛，這導致其在靜脈應用方面面臨更多挑戰。這限制了其在某些手術中的競爭柔軟性，這也是飛利浦在靜脈領域仍佔據主導地位的原因之一。

總體而言，周邊血管內超音波市場的競爭格局取決於導管產品的廣度、影像工作流程、已實施的主機的基礎以及透過一致的產品系列支援動脈和靜脈手術的能力。

科技和醫療治療的發展趨勢

周邊血管內超音波市場最重要的趨勢之一是高解析度成像技術的持續發展。影像品質的提升增強了血管的可見性，幫助醫生在介入治療過程中更有信心地做出決策。

另一個主要趨勢是導管小型化。隨著導管系統變得越來越小，導航性能也隨之提高，使得血管內超音波更容易在各種血管類型和手術環境中應用。

將血管內超音波（IVUS）引入靜脈領域也是一項重要的臨床趨勢。 IVUS 與深部靜脈介入治療的關聯日益緊密，這也是推動市場向非動脈疾病更廣泛應用方向發展的因素之一。

最後，血管內超音波（IVUS）的應用日益廣泛，不僅作為診斷輔助手段，更成為最佳化手術流程的工具。隨著醫師對介入治療精準度的要求越來越高，IVUS 在導管尺寸選擇、解剖結構確認、減少造影用量以及指導複雜病例等方面的作用也日益增強。

地區

本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球研究成果。

一份長達 68 頁的詳細市場分析、市場區隔和預測數據報告。

附錄：調查方法和縮寫詞彙表。

這份報告的意義

到 2032 年，全球周邊血管內超音波市場最大的成長機會在哪裡？

未來市場擴張將在多大程度上受到靜脈治療、周邊動脈疾病(PAD) 的增加以及 EVAR 或 TEVAR 的支持應用所驅動？

導管小型化和高解析度成像技術將在其未來的廣泛應用過程中發揮怎樣的作用？

資本成本、影像解讀挑戰與替代技術如何限制市場進一步滲透？

哪些主要企業在市場上處於領先地位？它們的導管產品系列如何影響它們的競爭地位？

供應商和投資者應該如何評估影像導引血管介入治療的未來前景，特別是周邊血管內超音波的作用？

iData Research 的《全球周邊血管內超音波市場報告》透過詳盡的市場規模、價格分析、競爭格局資訊和預測，解答了這些問題。您可以利用這份報告與競爭對手進行比較，評估影像主導的成長機遇，並在快速發展的周邊血管成像領域制定策略。

目錄

圖表清單

調查方法

• 第一步：計劃啟動與團隊組建
• 步驟 2：準備資料系統並進行二次調查。
• 步驟 3：設計和準備訪談和調查問卷。
• 第四步：進行初步調查
• 第五步：調查與分析：建立基準估計值
• 第六步：市場預測與分析
• 步驟 7：辨識策略機遇
• 步驟 8：最終審核和市場推廣
• 步驟九：客戶回饋與市場監測

全球關稅的影響

周邊血管內超音波市場

• 執行摘要
  • 全球周邊血管內超音波市場概覽
  • 競爭分析
  • 目標程式
  • 目標區域
• 介紹
• 手術次數
• 市場分析與預測
• 促進因素和抑制因素
• 競爭性市佔率分析

簡稱

Global Peripheral Intravascular Ultrasound Market Report

The global peripheral intravascular ultrasound market was valued at over $240 million in 2025. Over the forecast period, the market is expected to grow at a CAGR of 6.9% to reach $383 million by 2032.

• The full report suite on the global market for peripheral intravascular ultrasound, or IVUS, covers seven geographical regions: North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa. For each region, the report provides market valuation, unit analysis and average selling price data, while also extending projections through 2032 to provide a forward-looking view of market development. This description follows the same structure and sequencing used in the attached example document, adapted to the peripheral IVUS market and its specific clinical and commercial dynamics .

This report provides detailed analysis of the global peripheral IVUS market, including unit sales, procedure numbers, average selling prices, market size, market shares, growth trends and forecasts through 2032, with historical data to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and competitive analysis of the leading participants in the category. Although this is a more specialized imaging segment within peripheral vascular intervention, it is becoming increasingly important because physicians are relying more heavily on real-time vessel visualization during complex procedures.

A major trend shaping the market is the ongoing development of high-definition imaging technologies and smaller catheter systems. These improvements are helping physicians visualize vessel structures more clearly and navigate more effectively during intervention. As a result, IVUS is becoming more valuable in lesion assessment, stent sizing, post-placement optimization and treatment of complex anatomy. This is especially relevant in procedures where angiography alone may not provide enough detail to support confident decision-making.

Growth is also being driven by expanding use in venous intervention and by the steady rise in peripheral procedure volume associated with aging populations and higher peripheral arterial disease prevalence.

Market Overview

The global peripheral intravascular ultrasound market includes catheter-based imaging devices used to visualize blood vessels from inside the lumen during peripheral vascular procedures. Unlike angiography, which shows vessel outlines using contrast and X-ray imaging, IVUS provides real-time cross-sectional information about vessel size, plaque burden, lumen shape and wall structure. This makes it an important tool in procedures where accurate anatomical understanding can improve treatment planning and final procedural results.

Peripheral IVUS has become more relevant as vascular interventions have grown more complex. Many peripheral procedures now involve long lesions, calcified anatomy, venous obstruction, difficult access routes or borderline sizing decisions for stent grafts and other implants. In these situations, physicians often need more precise information than angiography alone can provide. IVUS addresses that need by helping define vessel diameter, lesion length, plaque composition and true lumen position during the procedure itself.

Overall, the peripheral IVUS market is positioned between imaging, intervention and procedural planning. It is not a therapy by itself, but it plays a key enabling role in helping physicians make better decisions during treatment. That role is becoming more important as peripheral interventions continue moving toward more complex and more image-dependent care.

Market Drivers

Venous Treatments

One of the strongest drivers in the global peripheral IVUS market is the growth of venous treatment. Philips, the market leader in IVUS, actively positioned its products alongside venous intervention, and this strategy helped make IVUS closely associated with deep venous procedures. After the results of the VIDIO trial, use of IVUS became more established in venous cases involving the inferior vena cava, common iliac vein, iliofemoral obstruction and common femoral vein obstruction.

This is highly important because penetration rates of IVUS in deep venous treatments are already over 50%. That level of established use means venous procedures are not just a future opportunity. They are already a major source of demand. As more venous disease is diagnosed and treated, this part of the market is expected to contribute meaningful growth. Because IVUS provides sizing and lesion detail that venography alone may miss, it has become an important part of workflow in many of these cases.

Demographic Factors Drive Peripheral Procedures

Another major growth driver is the aging global population. Peripheral arterial disease becomes more common with age, especially in patients aged 65 and older. As the number of older adults rises worldwide, the total number of peripheral vascular procedures is expected to increase. Even if IVUS penetration rates within those procedures do not change dramatically, a larger procedural base still supports higher catheter unit sales.

This driver is structural and long term. It is not tied to one company or one indication. Instead, it reflects the fact that more patients will require vascular intervention as the burden of PAD grows. Because IVUS is increasingly used to guide peripheral interventions, growth in the total number of cases supports continued expansion of the imaging category.

Clinical Advantages of IVUS in EVAR and TEVAR Procedures

Peripheral IVUS is also supported by its advantages in EVAR and TEVAR procedures. In these cases, IVUS can help assess anatomy when CT-based measurements are borderline or when anatomy may have changed between the original scan and the actual intervention. It can also help confirm key dimensions before device deployment, which improves physician confidence in stent graft selection and placement.

IVUS also helps reduce the amount of radiographic contrast needed during EVAR and TEVAR. This is useful because contrast media can cause patient discomfort and can be undesirable in patients with renal risk. In dissection cases, IVUS provides especially valuable guidance because it can help confirm that equipment remains within the true vessel lumen. The ability of IVUS to identify dissections at a much higher rate than angiography makes it a practical and clinically meaningful support tool in complex aortic work.

These benefits are important because they show that IVUS is not only a lesion imaging tool. It also functions as a procedural confirmation technology in some of the more technically demanding vascular cases. As EVAR and TEVAR continue evolving, this should help support growing adoption.

Market Limiters

Capital Equipment Cost Limits Adoption

The biggest limiter in the global peripheral IVUS market is the cost of capital equipment. An IVUS system requires both the disposable catheter and the IVUS console. While catheter use creates recurring revenue, the console represents a major upfront investment. For cost-sensitive hospitals and facilities, this can delay adoption even when physicians see clinical value in the technology.

This matters because installed base drives long-term catheter demand. If facilities delay purchasing the console, catheter unit growth is naturally limited as well. Smaller centers or lower-volume accounts may find it difficult to justify the initial investment, especially when competing imaging or procedural priorities exist.

Fuzzy Images and Learning Curve

Another important limiter is the challenge of image interpretation. IVUS images can be difficult for untrained users to read. They are often grainy and do not always provide the kind of easily intuitive detail seen in some other imaging modalities. Physicians need training and practical experience before they are comfortable using the technology confidently in routine practice.

The training burden is not extreme, but it is real. Any technology that requires added interpretation skill creates a barrier to wider use, especially in accounts where physician time is limited or where procedural teams are already comfortable with angiography. This can slow uptake and favor more familiar imaging methods.

Developing Technologies

Peripheral IVUS also faces competition from developing technologies such as OCT and CT-based vascular imaging. These are not yet the standard in the periphery, but their broader use in coronary procedures and ongoing reimbursement efforts around newer technologies suggest they could become more influential over time.

One reason this matters is that some alternative imaging approaches can generate cleaner visuals or more three-dimensional anatomical models. These capabilities can be useful in identifying dissections, thrombi, tissue prolapse and incomplete stent apposition. As these technologies continue to mature, they are expected to cannibalize part of the IVUS market.

Market Coverage and Data Scope

Quantitative Coverage

Market size, market shares, market forecasts, market growth rates, units sold and average selling prices.

Qualitative Coverage

Market drivers and limiters, growth trends, recent mergers and acquisitions, company profiles, product portfolios and leading competitors.

Time Frame

Base year 2025, historical data to 2022 and forecasts through 2032.

Regional Coverage

North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa.

Data Types Included

Unit sales, average selling prices, procedure numbers, market size and growth trends.

This report is designed to support strategic planning and competitive benchmarking by combining detailed market sizing with practical insight into where IVUS creates value within peripheral intervention.

Markets Covered and Segmentation

The report covers the Global Peripheral Intravascular Ultrasound Market.

This market is analyzed as a dedicated imaging category within peripheral vascular intervention. While the report does not subdivide the category into multiple device families in the same way as some larger therapeutic markets, it evaluates the full market by units, ASPs, market value, growth rates and regional performance.

The analysis supports understanding of peripheral IVUS use across arterial, venous and EVAR or TEVAR-related procedures, with forecasts through 2032 and historical data to 2022.

Competitive Analysis

Philips held the leading position in the peripheral IVUS catheter market in 2025. The company offers a broad peripheral IVUS catheter portfolio that includes Visions PV .018, Visions PV .035, Visions PV .014P and Visions PV .014P RX. Its Eagle Eye Platinum and Eagle Eye Platinum ST catheters are also used in both coronary and peripheral procedures and are compatible with the Core and Core Mobile IVUS consoles. Philips has a major competitive advantage because its phased-array IVUS catheters are generally viewed as simpler and more workflow-friendly than rotational IVUS catheters. The company is also the only major supplier with a full range of 0.014 inch, 0.018 inch and 0.035 inch peripheral IVUS catheter options, which strengthens its position across both arterial and venous indications. Its especially strong presence in venous work remains one of the clearest supports for its leadership.

Boston Scientific ranked second in the peripheral IVUS catheter market in 2025. Its position is supported by the OptiCross18 peripheral IVUS catheter, which works with the iLab and POLARIS systems. Boston Scientific performs well in peripheral arterial disease indications because of its broad peripheral intervention portfolio and the ability to pair IVUS with complementary treatment devices. However, the company faces more difficulty in venous indications because its catheter size offering is not as broad as Philips' lineup. This limits its competitive flexibility in some procedures and helps explain why Philips remains stronger in the venous segment.

Overall, competition in the peripheral IVUS market is shaped by catheter breadth, imaging workflow, installed console base and the ability to support both arterial and venous procedures through a coherent product portfolio.

Technology and Practice Trends

One of the most important trends in the peripheral IVUS market is the ongoing development of high-definition imaging technology. Better image quality improves vessel visualization and helps physicians make more confident decisions during intervention.

Another major trend is catheter miniaturization. Smaller catheter systems improve navigational capabilities and allow IVUS to be used more easily across different vessel types and procedural settings.

Venous adoption is also a key practice trend. IVUS is becoming strongly associated with deep venous intervention, and this is helping shift the market toward broader use in non-arterial cases.

Finally, IVUS is increasingly being used as a procedural optimization tool rather than only a diagnostic adjunct. Its role in sizing, confirming anatomy, reducing contrast use and guiding complex cases is expanding as operators seek more precision during intervention.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

68 pages of detailed market analysis, segmentation and forecast data.

Methodology Appendix and Acronym Glossary.

Why This Report

Where are the strongest growth opportunities in the global peripheral IVUS market through 2032?

How much of future expansion is being driven by venous procedures, PAD growth and EVAR or TEVAR support use?

What role do catheter miniaturization and higher-definition imaging play in future adoption?

How do capital costs, image interpretation challenges and alternative technologies limit broader market penetration?

Which companies lead the market, and how do their catheter portfolios shape their competitive positions?

How can suppliers and investors evaluate where peripheral IVUS fits within the broader future of image-guided vascular intervention?

The Global Peripheral Intravascular Ultrasound Market Report from iData Research answers these questions with detailed market sizing, pricing analysis, competitive intelligence and forecasting. Use it to benchmark competitors, evaluate imaging-driven growth opportunities and support strategy in a fast-evolving peripheral vascular imaging segment.

TABLE OF CONTENT

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Peripheral Intravascular Ultrasound Market

• 14.1 Executive Summary
  • 14.1.1 Global Peripheral Intravascular Ultrasound Market Overview
  • 14.1.2 Competitive Analysis
  • 14.1.3 Procedures Included
  • 14.1.4 Regions Included
• 14.2 Introduction
• 14.3 Procedure Numbers
• 14.4 Market Analysis And Forecast
• 14.5 Drivers And Limiters
  • 14.5.1 Market Drivers
  • 14.5.2 Market Limiters
• 14.6 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 14-1: Peripheral IVUS Market, Global, 2025 & 2032
• Chart 14-2: Peripheral IVUS Procedures, Global, 2025
• Chart 14-3: Peripheral IVUS Procedures by Region, Global, 2022 - 2032
• Chart 14-4: Peripheral IVUS Market, Global, 2022 - 2032
• Chart 14-5: Leading Competitors, Peripheral IVUS Market, Global, 2025

LIST OF FIGURES

• Figure 14-1: Peripheral IVUS Procedures Covered
• Figure 14-2: Peripheral IVUS Regions Covered, Global (1 of 2)
• Figure 14-3: Peripheral IVUS Regions Covered, Global (2 of 2)
• Figure 14-4: Peripheral IVUS Procedures by Region, Global, 2022 - 2032
• Figure 14-5: Peripheral IVUS Procedures by Country, North America, 2022 - 2032
• Figure 14-6: Peripheral IVUS Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 14-7: Peripheral IVUS Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 14-8: Peripheral IVUS Procedures by Country, Western Europe, 2022 - 2032
• Figure 14-9: Peripheral IVUS Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 14-10: Peripheral IVUS Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 14-11: Peripheral IVUS Procedures by Country, Middle East, 2022 - 2032
• Figure 14-12: Peripheral IVUS Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 14-13: Peripheral IVUS Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 14-14: Peripheral IVUS Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 14-15: Peripheral IVUS Procedures by Country, Africa, 2022 - 2032
• Figure 14-16: Peripheral IVUS Market, Global, 2022 - 2032
• Figure 14-17: Units Sold by Region, Peripheral IVUS Market, Global, 2022 - 2032
• Figure 14-18: Average Selling Price by Region, Peripheral IVUS Market, Global, 2022 - 2032 (US$)
• Figure 14-19: Market Value by Region, Peripheral IVUS Market, Global, 2022 - 2032 (US$M)
• Figure 14-20: Leading Competitors, Peripheral IVUS Market, Global, 2025